Recent trends in the epidemiology of inflammatory bowel diseases: up or down?
about
New Serological Markers for Inflammatory Bowel Disease Are Associated With Earlier Age at Onset, Complicated Disease Behavior, Risk for Surgery, and NOD2/CARD15 Genotype in a Hungarian IBD CohortNKX2-3 and IRGM variants are associated with disease susceptibility to IBD in Eastern European patientsA healthy gastrointestinal microbiome is dependent on dietary diversityPregnancy and inflammatory bowel diseases: Current perspectives, risks and patient managementCritical review: vegetables and fruit in the prevention of chronic diseasesEpidemiology of intrafamilial inflammatory bowel disease throughout EuropeThe dopaminergic system in autoimmune diseasesPotential treatment of inflammatory bowel disease: a review of helminths therapyImmunopathology of inflammatory bowel diseasePulmonary-intestinal cross-talk in mucosal inflammatory diseaseSystematic review with meta-analysis: infliximab and immunosuppressant therapy vs. infliximab alone for active ulcerative colitisRadiation enteropathy--pathogenesis, treatment and preventionSmoking in inflammatory bowel diseases: good, bad or ugly?The incidence of inflammatory bowel disease in Northern China: a prospective population-based studyFire in the belly and the professionalization of nurses: a historical analysis of Crohn disease care.The incidence of ulcerative colitis (1995-2011) and Crohn's disease (1995-2012) - based on nationwide Danish registry data.Participants' perspectives on mindfulness-based cognitive therapy for inflammatory bowel disease: a qualitative study nested within a pilot randomised controlled trialReduced microbial diversity and high numbers of one single Escherichia coli strain in the intestine of colitic mice.Bifidobacterium breve attenuates murine dextran sodium sulfate-induced colitis and increases regulatory T cell responsesInflammatory bowel disease: an expanding global health problemEvaluation of tumor necrosis factor (TNF)-α mRNA expression level and the rs1799964 polymorphism of the TNF-α gene in peripheral mononuclear cells of patients with inflammatory bowel diseases.Possible association of cutaneous Rosai-Dorfman disease and chronic Crohn disease: a case series report.Inflammatory bowel disease incidence in Czech children: A regional prospective study, 2000-2015Brief report: Risk of adverse fetal outcomes associated with immunosuppressive medications for chronic immune-mediated diseases in pregnancyAn LC-ESI-MS method for the quantitative analysis of bile acids composition in fecal materials.Is the disease course predictable in inflammatory bowel diseases?Epidemiology, demographic characteristics and prognostic predictors of ulcerative colitis.UNC5B receptor deletion exacerbates DSS-induced colitis in mice by increasing epithelial cell apoptosis.Assessment of causal link between psychological factors and symptom exacerbation in inflammatory bowel disease: a protocol for systematic review of prospective cohort studiesAutoimmunity and inflammation in X-linked agammaglobulinemia.Current status of thiopurine analogues in the treatment in Crohn's disease.Quality of life in patients with ulcerative colitis treated surgically.Long-term efficacy and safety of once-daily mesalazine granules for the treatment of active ulcerative colitis.Differentiation of Crohn's disease from intestinal tuberculosis in India in 2010.Medication adherence and persistence in the treatment of Canadian ulcerative colitis patients: analyses with the RAMQ database.Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn's diseaseIncidence and natural history of ulcerative colitis in the Uppsala Region of Sweden 2005-2009 - results from the IBD cohort of the Uppsala Region (ICURE).The genetic predisposition and the interplay of host genetics and gut microbiome in Crohn diseaseImmunohistochemical analysis of retinoblastoma and β-catenin as an assistant tool in the differential diagnosis between Crohn's disease and ulcerative colitis.Impaired deoxyribonuclease I activity in patients with inflammatory bowel diseases.
P2860
Q22242344-4C5A6DC6-2FBD-41CF-B99F-2A8AEDA27B80Q24613254-E6597833-D0B5-4B8D-9187-B1224FFA7485Q26750607-DCCF5338-BBB2-4A48-8BEC-741EE41A4204Q26777627-E181C1A7-1964-410C-989D-1693D1D15CD3Q26998728-305E6ED1-4679-4A19-A459-B14C1F63201FQ26999295-B2996BF3-BD96-4A14-B6C6-29C52F4EB737Q27023885-A175FD3A-65F9-474C-BECA-CD54F7736EB0Q27027621-E16BFB87-90CA-4CF5-8340-D5FEA9E881DBQ27027636-059A95DF-1A53-4912-9DA6-FCD4B8838650Q27693862-2D7C536B-A1E5-432B-AAF5-D5B6AB57CA38Q28088683-40E77D45-9B62-4163-A2E6-A67B5C8B4AD5Q28237189-73BB5B29-A0EF-4AAD-AE47-32D04FA9ABA1Q28260531-518E9BC9-BED7-49EC-B6B2-56CE49DE3FC0Q28655648-F9BA2594-3BB2-48E9-9836-611ED2241F55Q30415482-F1A18DE6-1484-4EAE-9EE9-42BB3500E2E7Q30787053-5DCBA7D4-949D-4DF9-83D5-E1FDFCAD8FB7Q30831712-50D18193-0C7E-48C8-8F72-668D84C26EE7Q33412853-D1F7C6F0-784C-44DE-AFBC-209800B37DEDQ33559718-A993D18F-D4C5-4181-B37C-0D41087F9B92Q33608406-BFD9A936-D8F0-471E-8CBB-2BB4046DC384Q33742101-69FCA5E9-5651-48A8-8369-49A5117CD961Q33760591-B3BB79B2-6926-4FAE-AE60-639B2AAD3082Q33805916-573CF739-40E1-4966-9C74-FF3DFCB33947Q33829396-9F6D14EF-8DCC-4376-B5D5-F7D9373A6876Q33862926-39FAC8EC-7DFD-4839-B706-43A4B1179F81Q33894191-17E932D5-2C60-417E-B20F-3B56F8B87D81Q33948374-8EF0D412-1741-4D45-91A2-27DEB9D01161Q33983402-A5DD8F31-24E1-44F8-A9B1-2F7DDD7040F6Q34035245-37E5B40E-A461-4158-BE83-69C69F2A7776Q34146476-579128C8-9F11-4E98-A62F-5C66BE134787Q34235370-9E91D663-FBD8-4FD9-9A92-1EDAB2785E49Q34258138-E37D34B9-6929-4851-8AB2-22E160C4A99AQ34273329-D7E3BDFA-6BD7-4AF7-9EA3-C9AE5CFAEAAFQ34521380-2B834090-1A00-4040-9C71-510A082905E0Q34567518-1EAC0BBB-70D6-443B-8F13-0D9AE30D07AFQ34610205-14DC01ED-0EBC-4FCF-89AE-C06AD797FA10Q34620405-B99D323F-5E5A-49F1-ADDD-0AC21DD85519Q34624820-B7E52463-EE69-43D0-B269-5612063A804AQ34962856-79A7F638-9383-419C-8BA7-F227322E22EDQ35038880-364EDBBC-BC90-4877-A7D4-6B899C8D8159
P2860
Recent trends in the epidemiology of inflammatory bowel diseases: up or down?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Recent trends in the epidemiology of inflammatory bowel diseases: up or down?
@en
Recent trends in the epidemiology of inflammatory bowel diseases: up or down?
@nl
type
label
Recent trends in the epidemiology of inflammatory bowel diseases: up or down?
@en
Recent trends in the epidemiology of inflammatory bowel diseases: up or down?
@nl
prefLabel
Recent trends in the epidemiology of inflammatory bowel diseases: up or down?
@en
Recent trends in the epidemiology of inflammatory bowel diseases: up or down?
@nl
P2860
P921
P356
P1476
Recent trends in the epidemiology of inflammatory bowel diseases: up or down?
@en
P2093
Peter-Laszlo Lakatos
P2860
P304
P356
10.3748/WJG.V12.I38.6102
P407
P577
2006-10-01T00:00:00Z